Utility of genomic assessment of blood-derived circulating tumor DNA (ctDNA) in patients with advanced lung adenocarcinoma

BACKGROUND: Genomic alterations in blood-derived circulating tumor DNA (ctDNA) from patients with non-small cell lung adenocarcinoma (NSCLC) were ascertained and correlated with clinical characteristics and therapeutic outcomes. METHODS AND FINDINGS: Comprehensive plasma ctDNA testing was performed...

Full description

Saved in:
Bibliographic Details
Published in:Clin Cancer Res
Main Authors: Schwaederlé, Maria C., Patel, Sandip P., Husain, Hatim, Ikeda, Megumi, Lanman, Richard B., Banks, Kimberly C., Talasaz, AmirAli, Bazhenova, Lyudmila, Kurzrock, Razelle
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5581668/
https://ncbi.nlm.nih.gov/pubmed/28539465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-16-2497
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items